title: Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy.
authors.affiliation: DuPont Merck Pharmaceutical Company, Wilmington, Delaware, USA.
authors.forename: R R
authors.initials: RR
authors.lastname: Wexler
authors.forename: W J
authors.initials: WJ
authors.lastname: Greenlee
authors.forename: J D
authors.initials: JD
authors.lastname: Irvin
authors.forename: M R
authors.initials: MR
authors.lastname: Goldberg
authors.forename: K
authors.initials: K
authors.lastname: Prendergast
authors.forename: R D
authors.initials: RD
authors.lastname: Smith
authors.forename: P B
authors.initials: PB
authors.lastname: Timmermans
mesh_terms: D057911:Angiotensin Receptor Antagonists; D000818:Animals; D000959:Antihypertensive Agents / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D011945:Receptors, Angiotensin / Q000145:classification; D013329:Structure-Activity Relationship
chemical_list: D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D011945:Receptors, Angiotensin